Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234236 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
A postoperative adjuvant program using combination chemotherapy with gemcitabine and either cisplatin or capecitabine followed by radiotherapy with capecitabine is tolerable and efficacious and should be considered for Phase III testing in this group of patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sameer M.D., Edgar M.D., Kent A. M.S., Diane M.D., Joel K. M.D., Isaac R. M.D., Janet R.N., Lisa M.D., Alfred E. M.D., Theodore S. M.D., Ph.D., Mark M. M.D.,